MA28943B1 - Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations - Google Patents

Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations

Info

Publication number: MA28943B1
Authority: MA; Morocco
Prior art keywords: methods; receptor binding; mimetic; compositions; melanocortin receptor
Prior art date: 2004-10-25

Application number

MA29843A

Other languages

English (en)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Centocor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2007-04-23

Publication date

2007-10-01

2007-04-23 Application filed by Centocor Inc filed Critical Centocor Inc

2007-10-01 Publication of MA28943B1 publication Critical patent/MA28943B1/fr

Links

102000004378 Melanocortin Receptors Human genes 0.000 title abstract 2
108090000950 Melanocortin Receptors Proteins 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
102000040430 polynucleotide Human genes 0.000 abstract 2
108091033319 polynucleotide Proteins 0.000 abstract 2
239000002157 polynucleotide Substances 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Hematology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA29843A 2004-10-25 2007-04-23 Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations MA28943B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25

Publications (1)

Publication Number	Publication Date
MA28943B1 true MA28943B1 (fr)	2007-10-01

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29843A MA28943B1 (fr)	2004-10-25	2007-04-23	Corps mimetiques de liaison au recepteur de la melanocortine, compositions, procedes et utilisations

Country Status (28)

Country	Link
US (1)	US20060105951A1 (fr)
EP (1)	EP1812046B1 (fr)
JP (1)	JP2008517605A (fr)
KR (1)	KR101255140B1 (fr)
CN (1)	CN101437540B (fr)
AT (1)	ATE501731T1 (fr)
AU (1)	AU2005299440B2 (fr)
BR (1)	BRPI0518411A2 (fr)
CA (1)	CA2585287A1 (fr)
CY (1)	CY1111486T1 (fr)
DE (1)	DE602005026970D1 (fr)
DK (1)	DK1812046T3 (fr)
EA (1)	EA200700944A1 (fr)
EC (1)	ECSP077416A (fr)
ES (1)	ES2363023T3 (fr)
HR (1)	HRP20110405T1 (fr)
IL (1)	IL182683A0 (fr)
MA (1)	MA28943B1 (fr)
ME (1)	ME01234B (fr)
MX (1)	MX2007004974A (fr)
NO (1)	NO20072499L (fr)
PL (1)	PL1812046T3 (fr)
PT (1)	PT1812046E (fr)
RS (1)	RS51789B (fr)
SI (1)	SI1812046T1 (fr)
TN (1)	TNSN07157A1 (fr)
WO (1)	WO2006047535A2 (fr)
ZA (1)	ZA200704260B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) *	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
AR072072A1 (es) *	2008-06-09	2010-08-04	Palatin Technologies Inc	Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
EP2300036B1 (fr)	2008-06-09	2017-04-05	Palatin Technologies, Inc.	Peptides spécifiques du récepteur de mélanocortine pour le traitement d'un dysfonctionnement sexuel
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt)	2009-06-08	2022-02-08	Palatin Technologies, Inc	Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
WO2010144341A2 (fr)	2009-06-08	2010-12-16	Palatin Technologies, Inc.	Peptides spécifiques des récepteurs aux mélanocortines à pont lactame
EP2504351A4 (fr)	2009-11-23	2013-10-30	Palatin Technologies Inc	Peptides linéaires spécifiques du récepteur de la mélanocortine-1
AU2010321738B2 (en)	2009-11-23	2016-07-14	Palatin Technologies, Inc.	Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (fr) *	2019-03-02	2020-09-10	上海一宸医药科技有限公司	Anticorps bispécifique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01005818A (es) *	1998-12-09	2003-07-21	Eleanor Rooseveltl Inst	Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (fr) *	2000-07-14	2002-01-24	Zycos, Inc.	Composes en rapport avec $g(a)-msh et methodes d'utilisation
WO2004002417A2 (fr) *	2002-06-28	2004-01-08	Centocor, Inc.	Corps mimetiques mammaliens a deletion ch1, compositions, procedes et utilisations
US7241733B2 (en) *	2002-06-28	2007-07-10	Centocor, Inc.	Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
EP1750754A4 (fr) *	2004-03-31	2010-09-22	Centocor Ortho Biotech Inc	Corps mimetiques glp-1 humains, compositions, procedes et utilisations

2005
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es not_active Expired - Lifetime
- 2005-10-25 HR HR20110405T patent/HRP20110405T1/hr unknown
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 EP EP05819741A patent/EP1812046B1/fr not_active Expired - Lifetime
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/fr not_active Ceased
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active Expired - Fee Related
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/fr unknown
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 RS RS20110230A patent/RS51789B/sr unknown
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de not_active Expired - Lifetime
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 CA CA002585287A patent/CA2585287A1/fr not_active Abandoned
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown

Also Published As

Publication number	Publication date
WO2006047535A2 (fr)	2006-05-04
ATE501731T1 (de)	2011-04-15
HK1106445A1 (en)	2008-03-14
EP1812046B1 (fr)	2011-03-16
PT1812046E (pt)	2011-06-28
SI1812046T1 (sl)	2011-06-30
ZA200704260B (en)	2009-03-25
CA2585287A1 (fr)	2006-05-04
US20060105951A1 (en)	2006-05-18
WO2006047535A3 (fr)	2008-09-04
PL1812046T3 (pl)	2011-08-31
IL182683A0 (en)	2007-09-20
RS51789B (sr)	2011-12-31
BRPI0518411A2 (pt)	2008-11-18
KR101255140B1 (ko)	2013-04-22
EA200700944A1 (ru)	2008-04-28
CY1111486T1 (el)	2015-08-05
HRP20110405T1 (hr)	2011-06-30
AU2005299440B2 (en)	2011-12-15
DK1812046T3 (da)	2011-06-06
CN101437540B (zh)	2012-12-19
CN101437540A (zh)	2009-05-20
NO20072499L (no)	2007-07-16
ECSP077416A (es)	2007-05-30
JP2008517605A (ja)	2008-05-29
ME01234B (fr)	2013-06-20
KR20070085416A (ko)	2007-08-27
DE602005026970D1 (de)	2011-04-28
EP1812046A2 (fr)	2007-08-01
MX2007004974A (es)	2007-10-17
TNSN07157A1 (en)	2008-11-21
EP1812046A4 (fr)	2009-11-11
ES2363023T3 (es)	2011-07-19
AU2005299440A1 (en)	2006-05-04

Publication	Publication Date	Title
NO20072499L (no)	2007-07-16	Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser
NO345048B1 (no)	2020-09-07	Antigen-bindende protein som binder til humant IGF-1R, polynukleotid som koder for dette, samt plasmid og celle, og farmasøytisk sammensetning.
EP1907001A4 (fr)	2010-01-13	Molecules de liaison ilt3 et leurs utilisations
DK1864132T3 (da)	2012-07-16	Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
NO20024489D0 (no)	2002-09-19	Multifunksjonelle polypeptider som omfatter et bindingssete til et epitop i NKG2D reseptor-komplekset
WO2007104062A3 (fr)	2008-11-27	Compositions et procédés concernant le profilage d'une pluralité de lignées cellulaires en fonction de leur liaison à des peptides
EA201490263A1 (ru)	2014-10-30	Связующие и изготовленные с их помощью материалы
ATE539170T1 (de)	2012-01-15	Abschätzung und verringerung des risikos von graft-versus-host-reaktion
EP1553975A4 (fr)	2006-09-27	Variants fc optimises et methodes destinees a leur generation
BRPI0613770A2 (pt)	2009-05-19	anticorpos anti-cd26 e métodos de uso destes
NO20062087L (no)	2006-07-07	Bispesifikt antistoff som substituerer for funksjonelle proteiner
NO20066050L (no)	2007-02-05	Substituerte indazoler, sammensetninger inneholdende disse samt fremstilling og anvendelse derav
ATE493081T1 (de)	2011-01-15	Faserverstärktes verbundmaterial
NO20091181L (no)	2009-05-18	Anti-C5AR-antistoffer med forbedrede egenskaper
DK1328297T3 (da)	2010-02-01	Funktionen af en haptoglobin-hæmoglobin receptor og anvendelser heraf
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
CR9637A (es)	2008-03-06	Proteinas de enlace il-6
MX2009006879A (es)	2009-07-03	Anticuerpos contra el cd200r.
WO2007030426A3 (fr)	2007-07-26	Procedes d'utilisation et d'analyse de donnees de sequences biologiques
WO2005028497A3 (fr)	2006-02-23	Peptides se liant a des recepteurs derives de proteines sars s
NO20085224L (no)	2009-02-26	Vurdering av funksjonell status
WO2007008539A3 (fr)	2007-05-10	Composes chimiques
ATE471169T1 (de)	2010-07-15	Engineering mit homing-faktoren
EP2488200A4 (fr)	2013-06-12	Antagonistes d'april et méthodes d'utilisation
MX2007010332A (es)	2008-02-21	Metodos y composiciones para promover adhesion o migracion de celula endotelial.